- Global Pharma News & Resources

Targovax ASA: Invitation to Second Quarter and First Half Year 2018 Results Presentation Thursday 23 August

OSLO, Norway, Aug 15, 2018 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, will announce its second quarter and first half year 2018 results on Thursday, 23 August 2018. A presentation by Targovax's management to investors, analysts and the press will take place in Oslo at 10:00 CET.

The results report and the presentation will be available at in the Investors section from 07:00 CET.


The presentation will take place at 10:00 CET at:

Hotel Continental

Stortingsgaten 24/26

0117 Oslo

The presentation will also be webcast live and can be accessed through

For further information, please contact:

Renate Birkeli, Investor Relations

Phone: +47-922-61-624


Media and IR enquires:

Andreas Tinglum - Corporate Communications (Norway)

Phone: +47-9300-1773


Simon Conway/Stephanie Cuthbert - FTI Consulting (International)

Phone: +44-20-3727-1000


This information was brought to you by Cision,c2592197

Editor Details

Related Links

Last Updated: 16-Aug-2018